Subcutaneous tissue disease Advocacy Hub | UniteRare

At a Glance

Live from database

Regulatory Watchboard

10 events

Apr 2026A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With HR+, HER2- Advanced Breast Cancer

TerSera Therapeutics LLC — PHASE1

TrialNOT YET RECRUITING

Mar 2026NIS to Examine Disease Activity in SLE Patients Treated With Subcutaneous Anifrolumab in Routine Care

AstraZeneca

TrialNOT YET RECRUITING

Mar 2026A Phase I Study of Single Subcutaneous Dose of SHR-1894 in Healthy Subjects

Suzhou Suncadia Biopharmaceuticals Co., Ltd. — PHASE1

TrialRECRUITING

Feb 2026A Study of Eloralintide (LY3841136) in Participants With Different Levels of Liver Damage and in Participants With Healthy Livers.

Eli Lilly and Company — PHASE1

TrialRECRUITING

Feb 2026Upper Body Subcutaneous Exosome Release in Response to a Meal in Obesity

Mayo Clinic — NA

TrialNOT YET RECRUITING

Dec 2025A Phase II, Multicenter, Open-label Study to Evaluate the Efficacy and Safety of Neoadjuvant Therapy With Inavolisib Plus Pertuzumab and Trastuzumab as Subcutaneous (PH-FDC SC) and 3-week Cycle Nab-paclitaxel for PIK3CA-mutated, HER2+, eBC

Zhimin Shao — PHASE2

TrialNOT YET RECRUITING

Nov 2025A Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Psoriatic Arthritis

MoonLake Immunotherapeutics AG — PHASE3

TrialENROLLING BY INVITATION

Oct 2025Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM1812 Injection Following Single and Multiple Subcutaneous Administration in Normal to Overweight or Obese But Otherwise Healthy Men and Women

BrightGene Bio-Medical Technology Co., Ltd. — PHASE1

TrialRECRUITING

Aug 2025A Trial of SHR-1139 in Healthy Volunteers

Atridia Pty Ltd. — PHASE1

TrialACTIVE NOT RECRUITING

Aug 2025Neoadjuvant Oral Paclitaxel Plus Subcutaneous Pertuzumab/Trastuzumab in Patients With HER2-positive Breast Cancer

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University — NA

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for Subcutaneous tissue disease.
Check the disease page for updates →

Clinical Trial Landscape

No active clinical trials currently recruiting for Subcutaneous tissue disease.
Search all trials →

Search clinical trials for Subcutaneous tissue disease →

Recent News & Research

No recent news articles indexed yet for Subcutaneous tissue disease.
Search PubMed for Subcutaneous tissue disease →

Browse all Subcutaneous tissue disease news →

Specialist Network

Top 6 by expertise

Mikhail Samsonov

R-Pharm

Score 2717 trials

Gary Weil, MD, M.D

Washington University School of Medicine

📍 BELLEVUE, WA

Score 195 trials1 pub

Peter Fischer, PhD

Washington University School of Medicine

Score 171 trial

Patrick Kpanyen, PhD

National Public Health Institute of Liberia

Score 81 trial

Tracey McLaughlin, MD

Stanford University

Score 55 trials

Michael Blue, MD

Cardinal Health 414, LLC

Score 43 trials

View all Subcutaneous tissue disease specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰